On 6 February 2016
Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 6 February 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter ended 31 December 2015.Powered by Capital Market - Live News
